FLT1 and lung adenocarcinoma: Yuan et al. described that the expression of VEGF‐A, VEGFR1, and VEGFR2 was analyzed using immunohistochemistry in 104 patients with EGFR‐mutated lung adenocarcinoma who did not receive EGFR‐TKIs.18